Bepotastine Besilate Ophthalmic Solution 1.5%

bepotastine besilate ophthalmic solution 1.5% · Alembic Pharmaceuticals Limited

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Bepotastine Besilate Ophthalmic Solution 1.5%, covering 2023-04-05 to 2023-04-05. Get the full timeline:

Most recent: FDA Approved: BEPOTASTINE BESILATE OPHTHALMIC SOLUTION 1.5% — Original Application (Alembic Pharmaceuticals Limited)